Role of Polo-Like Kinase-1 in Melanocytic Transformation

Polo 样激酶 1 在黑素细胞转化中的作用

基本信息

  • 批准号:
    8492041
  • 负责人:
  • 金额:
    $ 30.31万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-07-01 至 2015-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Understanding of the mechanisms of melanocytic transformation is a continuing challenge. An in- depth knowledge of the genetic controls of cellular proliferation and cell division may provide critical information regarding the conversion of a normal melanocyte to its neoplastic phenotype. Polo-like kinases (Plks) are a family of highly conserved mitotic serine/threonine kinases that have been shown to play critical roles in cell division and cycle progression. Plk1 is the most widely studied member of the Plk family that contributes to multiple mitotic processes including the activation of the Cdk1/Cyclin B1 cascade, centrosome maturation, bipolar spindle formation and the regulation of Emi1 degradation at mitotic exit. Plk1 has been shown to be over-expressed in several cancers and a forced over-expression of Plk1 in normal cells has been found to cause a transformed phenotype and increased tumorigenicity. However, the functional role of Plk1 in melanocytic transformation is not well understood. In a recent study (J Invest Dermatol, In Press; Appendix-1), we have found that, i) Plk1 was over-expressed in both clinical tissue specimens and cultured human melanoma cells when compared to normal skin tissues and cultured normal melanocytes, respectively; and ii) genetic as well as chemical inhibition of Plk1 resulted in a significant decrease in the viability and growth of melanoma cells without affecting the normal human melanocytes. This study suggested that Plk1 may have an important role in melanoma survival and/or progression. However, additional studies are needed to determine the functional significance of Plk1 in melanocytic transformation and to define its molecular mechanism(s). In this study, we propose to challenge our novel hypothesis that Plk1 plays a critical role in melanocytic transformation and melanoma survival through modulation of Notch signaling. To test the hypothesis, the following specific aims are proposed: 1) To determine the expression pattern of Plk1, Notch and Numb during melanocytic transformation and melanoma development; 2) To determine the involvement of Notch signaling as a downstream target of Plk1 in normal melanocytes and melanoma cells; 3) To define the mechanism by which Plk1 regulates Notch1 signaling; and 4) To determine the functional and therapeutic significance of Plk1 in vivo in athymic nude mice xenografts. The outcome of proposed studies may define i) the role of Plk1 in melanocytic transformation and melanoma progression, ii) a novel connection between a key mitotic regulator (Plk1) with an important signaling pathway (Notch) involved in multiple cellular processes, including melanoma development.
描述(由申请人提供): 了解黑素细胞转化的机制是一个持续的挑战。对细胞增殖和细胞分裂的遗传控制的深入了解可能会提供有关正常黑素细胞转化为肿瘤表型的关键信息。 polo样激酶(PLK)是一个高度保守的有丝氨酸/苏氨酸激酶的家族,这些家族已被证明在细胞分裂和循环进程中起着关键作用。 PLK1是PLK家族中研究最广泛的成员,它有助于多种有丝分裂过程,包括激活CDK1/Cyclin B1级联反应,中心体成熟,双极纺锤体形成以及在有丝分裂出口时EMI1降解的调节。已显示PLK1在几种癌症中被表达过表达,并且已发现正常细胞中PLK1的强制表达会导致转化的表型和增加的肿瘤性。但是,PLK1在黑素细胞转化中的功能作用尚不清楚。在最近的一项研究(J Invest Dermatol,在印刷中;附录1),我们发现,与正常的皮肤组织和培养的正常黑素细胞相比,i)PLK1在临床组织样本和培养的人黑色素瘤细胞中都过表达。 ii)遗传和化学抑制PLK1导致黑色素瘤细胞的生存力和生长显着降低,而不会影响正常的人黑色素细胞。这项研究表明,PLK1可能在黑色素瘤存活和/或进展中起重要作用。但是,需要进行其他研究来确定PLK1在黑素细胞转化中的功能意义并定义其分子机制。在这项研究中,我们建议挑战我们的新假设,即PLK1通过调节Notch信号传导在黑素细胞转化和黑色素瘤存活中起关键作用。为了检验假设,提出了以下特定目的:1)确定在黑色素细胞转化和黑色素瘤发育过程中PLK1,缺口和麻木的表达模式; 2)确定Notch信号作为PLK1的下游靶标在正常的黑色素细胞和黑色素瘤细胞中; 3)定义PLK1调节Notch1信号传导的机制; 4)确定plk1在无胸腺裸鼠异种移植物中体内的功能和治疗意义。拟议研究的结果可能定义了i)PLK1在黑色素细胞转化和黑色素瘤进展中的作用,ii)与多种细胞过程有关的重要信号传导途径(Notch)之间的关键有丝分裂调节剂(PLK1)之间的新联系,包括黑色素瘤发育。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nihal Ahmad其他文献

Nihal Ahmad的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nihal Ahmad', 18)}}的其他基金

Combined inhibition of PLK1 and NOTCH for melanoma management
联合抑制 PLK1 和 NOTCH 治疗黑色素瘤
  • 批准号:
    10481129
  • 财政年份:
    2023
  • 资助金额:
    $ 30.31万
  • 项目类别:
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
  • 批准号:
    10481027
  • 财政年份:
    2022
  • 资助金额:
    $ 30.31万
  • 项目类别:
Functional and Therapeutic Significance of PLK4 in Melanoma
PLK4 在黑色素瘤中的功能和治疗意义
  • 批准号:
    10442947
  • 财政年份:
    2022
  • 资助金额:
    $ 30.31万
  • 项目类别:
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
  • 批准号:
    10593106
  • 财政年份:
    2022
  • 资助金额:
    $ 30.31万
  • 项目类别:
Functional and Therapeutic Significance of PLK4 in Melanoma
PLK4 在黑色素瘤中的功能和治疗意义
  • 批准号:
    10671687
  • 财政年份:
    2022
  • 资助金额:
    $ 30.31万
  • 项目类别:
Role of sirtuin 6 in melanoma development and progression
Sirtuin 6 在黑色素瘤发生和进展中的作用
  • 批准号:
    10426079
  • 财政年份:
    2021
  • 资助金额:
    $ 30.31万
  • 项目类别:
Role of sirtuin 6 in melanoma development and progression
Sirtuin 6 在黑色素瘤发生和进展中的作用
  • 批准号:
    10595641
  • 财政年份:
    2021
  • 资助金额:
    $ 30.31万
  • 项目类别:
Role of polo like kinase 4 in melanomagenesis and melanoma progression
Polo 样激酶 4 在黑色素瘤发生和黑色素瘤进展中的作用
  • 批准号:
    10046297
  • 财政年份:
    2018
  • 资助金额:
    $ 30.31万
  • 项目类别:
Role of polo like kinase 4 in melanomagenesis and melanoma progression
Polo 样激酶 4 在黑色素瘤发生和黑色素瘤进展中的作用
  • 批准号:
    9551225
  • 财政年份:
    2018
  • 资助金额:
    $ 30.31万
  • 项目类别:
Role of polo like kinase 4 in melanomagenesis and melanoma progression
Polo 样激酶 4 在黑色素瘤发生和黑色素瘤进展中的作用
  • 批准号:
    10421255
  • 财政年份:
    2018
  • 资助金额:
    $ 30.31万
  • 项目类别:

相似海外基金

Optimization and Validation of a Cost-effective Image-Guided Automated Extracapsular Extension Detection Framework through Interpretable Machine Learning in Head and Neck Cancer
通过可解释的机器学习在头颈癌中优化和验证具有成本效益的图像引导自动囊外扩展检测框架
  • 批准号:
    10648372
  • 财政年份:
    2023
  • 资助金额:
    $ 30.31万
  • 项目类别:
Impact of the COVID-19 pandemic on newly-diagnosed breast cancer
COVID-19 大流行对新诊断乳腺癌的影响
  • 批准号:
    10359555
  • 财政年份:
    2022
  • 资助金额:
    $ 30.31万
  • 项目类别:
Impact of the COVID-19 pandemic on newly-diagnosed breast cancer
COVID-19 大流行对新诊断乳腺癌的影响
  • 批准号:
    10544316
  • 财政年份:
    2022
  • 资助金额:
    $ 30.31万
  • 项目类别:
SITE LICENSE TO AJCC CANCER STAGING MANUAL, 8TH EDITION
AJCC 癌症分期手册第 8 版网站许可
  • 批准号:
    10360405
  • 财政年份:
    2021
  • 资助金额:
    $ 30.31万
  • 项目类别:
Longitudinal Spatial-Nonspatial Decision Support for Competing Outcomes in Head and Neck Cancer Therapy
头颈癌治疗竞争结果的纵向空间-非空间决策支持
  • 批准号:
    10185481
  • 财政年份:
    2021
  • 资助金额:
    $ 30.31万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了